EGFR and hepatocellular carcinoma: When we exposed cells to a combination of EGFR-TKIs with 10 μg/mL of mAbs, no significant decrease of cell viability was observed in MDA-MB-231 and HCC-1937 cells compared with EGFR-TKIs treatment alone.